Watershed Asset Management, L.L.C. Eagle Pharmaceuticals, Inc. Transaction History

Watershed Asset Management, L.L.C.

  • $85.3 Million
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023
BUY
$25.06 - $34.09 $8,720 - $11,863
348 Added 3.8%
9,496 $269,000
Q4 2022

Feb 03, 2023
BUY
$24.98 - $39.77 $31,924 - $50,826
1,278 Added 16.24%
9,148 $267,000
Q3 2022

Nov 14, 2022
BUY
$26.42 - $47.12 $55,851 - $99,611
2,114 Added 36.73%
7,870 $208,000
Q2 2022

Aug 05, 2022
BUY
$41.26 - $51.35 $237,492 - $295,570
5,756 New
5,756 $256,000

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Watershed Asset Management, L.L.C. Portfolio

Follow Watershed Asset Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Watershed Asset Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Watershed Asset Management, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email